Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi's Dengue Vaccine Health Warning Seen Hitting Product's Sales

Nov 30 2017

• By Sten Stovall

Dengue virus vaccine — Sanofi's Dengue Vaccine Is More Risky For People Without Prior Infection • Source: Shutterstock

Related Content

Sanofi's Dengue Vaccine Is World's First Approved

Dec 10 2015

Data Add To Strengthening Efficacy Case For Takeda Dengue Vaccine

Mar 30 2017

Takeda's Dengue Vaccine Still Promising, But Could Be A Niche Market

Nov 07 2017

Related Companies

Sanofi

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Clinical Trials Commercial Companies Safety Vaccines Infectious Diseases BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.